Q&A with Judith Ng-Cashin, CRO Novotech's chief medical officer, on 2023 and beyond
Last month, Judith Ng-Cashin became Novotech’s first chief medical officer, with an eye toward expanding the Asia-Pacific contract research organization (CRO) farther West.
Ng-Cashin, who brings two decades of international pharma, biotech and CRO experience to lead Novotech’s global medical services team, chatted with Endpoints News on Friday regarding the current landscape for CROs, biotech companies and more. This conversation has been edited and condensed for clarity.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.